Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Safety, Efficacy and Tolerability of PreLipid®, a Twice-daily Nutritional Supplement in Subjects With Higher Than Normal Blood Lipid Levels

NCT02187757 is registered in ClinicalTrials.gov with PreEmptive Meds, Pvt. Ltd as lead sponsor.

NCT NCT02187757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02187757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Safety, Efficacy and Tolerability of PreLipid®, a Twice-daily Nutritional Supplement in Subjects With Higher Than Normal Blood Lipid Levels
Lead sponsor
PreEmptive Meds, Pvt. Ltd
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2014
Enrollment
180 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia